KBC Group NV decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 319,728 shares of the healthcare conglomerate’s stock after selling 16,120 shares during the period. KBC Group NV’s holdings in UnitedHealth Group were worth $52,438,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC boosted its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the period. Founders Capital Management purchased a new stake in UnitedHealth Group during the first quarter valued at $135,000. Parkside Financial Bank & Trust boosted its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Hanson McClain Inc. boosted its stake in UnitedHealth Group by 1.7% in the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the period. 86.21% of the stock is owned by institutional investors.

UnitedHealth Group Incorporated (NYSE UNH) traded up 0.536% on Monday, hitting $195.401. 367,840 shares of the company were exchanged. The stock has a market cap of $188.93 billion, a PE ratio of 23.474 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The firm has a 50 day moving average of $191.39 and a 200-day moving average of $177.03.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period last year, the company posted $1.96 earnings per share. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s payout ratio is 35.13%.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://theolympiareport.com/2017/08/28/kbc-group-nv-decreases-position-in-unitedhealth-group-incorporated-unh.html.

Several analysts have recently weighed in on the stock. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday. Morgan Stanley increased their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Cowen and Company reissued an “outperform” rating and issued a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price target for the company in a research note on Tuesday, August 1st. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $203.41.

In other news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,540 shares of company stock valued at $5,748,970. Corporate insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.